QuiVad

Home / United States / Molecular Partners AG Ordinary (MLLCF)

Molecular Partners AG Ordinary (MLLCF)

Short position disclosed on September 15, 2026.

Follow

FINRA publishes, twice a month, the number of shares sold short in each company. Their share of the stock is computed here on the count the company reports to the SEC, and this market appears in no ranking shared with the others.

Evolution of the disclosed total

020K40K60K80K
Jul 30Aug 14Aug 29Sep 13
Number of shares sold short. Hover or tap the curve to see which funds make it up.

Open positions

The funds disclosing a short position that is still open.
FundTwelve monthsShares sold shortOver the yearSince
Aggregated total58,282 shares-10,092 sharesSeptember 15, 2026

Follow by RSS

Get the moves on Molecular Partners AG Ordinary (MLLCF) by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

5 disclosures on record for this share.
DateFundShares sold shortEnd of publication
September 15, 2026Aggregated total58,282 sharesstill open
August 31, 2026Aggregated total64,260 shares
August 14, 2026Aggregated total68,673 shares
July 31, 2026Aggregated total68,424 shares
July 15, 2026Aggregated total68,374 shares

Download 5 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the United States

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Molecular Partners AG Ordinary (MLLCF), source FINRA, data as at September 15, 2026, https://www.quivad.com/action/molecular-partners-ag-ordinary-mllcf